Anticorps Polyclonal de lapin anti-C12orf65

C12orf65 Polyclonal Antibody for IHC, Indirect ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain

Applications

IHC, Indirect ELISA

Conjugaison

Non conjugué

N° de cat : 24646-1-PBS

Synonymes

---

Galerie de données de validation

• 

  IHC staining of human kidney using 24646-1-AP (same clone as 24646-1-PBS)

  Immunohistochemical analysis of paraffin-embedded human kidney tissue slide using 24646-1-AP (C12orf65 antibody) at dilution of 1:100 (under 10x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0). This data was developed using the same antibody clone with 24646-1-PBS in a different storage buffer formulation.

• 

  IHC staining of human kidney using 24646-1-AP (same clone as 24646-1-PBS)

  Immunohistochemical analysis of paraffin-embedded human kidney tissue slide using 24646-1-AP (C12orf65 antibody) at dilution of 1:100 (under 40x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0). This data was developed using the same antibody clone with 24646-1-PBS in a different storage buffer formulation.

---

Informations sur le produit

24646-1-PBS cible C12orf65 dans les applications de IHC, Indirect ELISA et montre une réactivité avec des échantillons Humain

• Réactivité: Humain
• Hôte / Isotype: Lapin / IgG
• Clonalité: Polyclonal
• Type: Anticorps
• Immunogène: C12orf65 Protéine recombinante Ag19965
• Nom complet: chromosome 12 open reading frame 65
• Masse moléculaire calculée: 166 aa, 19 kDa
• Numéro d’acquisition GenBank: BC062329
• Symbole du gène: C12orf65
• Identification du gène (NCBI): 91574
• Conjugaison: Non conjugué
• Forme: Liquide
• Méthode de purification: Purification par affinité contre l'antigène
• Tampon de stockage: PBS only
• Conditions de stockage: Store at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

C12orf65 participates in the process of mitochondrial translation and has been shown to be associated with a spectrum of phenotypes, including early onset optic atrophy, progressive encephalomyopathy, peripheral neuropathy, and spastic paraparesis.

{{ptg:RelatedPrimaryAntibodies}}